Market Overview

Jefferies Raises PT on ViroPharma to $33

Jefferies & Company has raised the price target on ViroPharma (NASDAQ: VPHM) from $28 to $33 and maintains its Buy rating.

Posted-In: Jefferies & CompanyPrice Target Pre-Market Outlook Analyst Ratings

 

Most Popular

Related Articles (VPHM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters